[Mechanism of action of naphthoquinones and hydroxycoumarins on the mechano-active properties of isolated coronary arteries]. 1987

V A Lider, and S B Shishkin, and S N Feofilaktova

The action of natural naphthoquinones and their antagonists oxicoumarins on mechanoactive properties of isolated coronary arteries was studied in experiments on male albino rats. Vitamin K deficiency (primary, secondary) was found to be accompanied with disturbances of mechanoactive properties of the heart vessels Naphthoquinones (vitamins K1 and K3) exerted a spasmolytic action on coronary vessels of intact animals and animals with vitamin K deficiency as well. These effects are supposed to be probably related to the redistribution of cations Ca2+ and K+ in membranes.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009285 Naphthoquinones Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. Naphthalenediones,Naphthazarins,Naphthoquinone
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas
D001696 Biomechanical Phenomena The properties, processes, and behavior of biological systems under the action of mechanical forces. Biomechanics,Kinematics,Biomechanic Phenomena,Mechanobiological Phenomena,Biomechanic,Biomechanic Phenomenas,Phenomena, Biomechanic,Phenomena, Biomechanical,Phenomena, Mechanobiological,Phenomenas, Biomechanic
D014813 Vitamin K Deficiency A nutritional condition produced by a deficiency of VITAMIN K in the diet, characterized by an increased tendency to hemorrhage (HEMORRHAGIC DISORDERS). Such bleeding episodes may be particularly severe in newborn infants. (From Cecil Textbook of Medicine, 19th ed, p1182) Deficiency, Vitamin K,Deficiencies, Vitamin K,Vitamin K Deficiencies

Related Publications

V A Lider, and S B Shishkin, and S N Feofilaktova
July 1984, Circulation research,
V A Lider, and S B Shishkin, and S N Feofilaktova
January 1965, Archivio di scienze biologiche,
V A Lider, and S B Shishkin, and S N Feofilaktova
January 1987, Cor et vasa,
V A Lider, and S B Shishkin, and S N Feofilaktova
January 1969, Naunyn-Schmiedebergs Archiv fur Pharmakologie,
V A Lider, and S B Shishkin, and S N Feofilaktova
October 1974, The Journal of pharmacology and experimental therapeutics,
V A Lider, and S B Shishkin, and S N Feofilaktova
July 1985, Canadian journal of physiology and pharmacology,
V A Lider, and S B Shishkin, and S N Feofilaktova
January 1988, Drugs under experimental and clinical research,
V A Lider, and S B Shishkin, and S N Feofilaktova
November 1996, American journal of obstetrics and gynecology,
V A Lider, and S B Shishkin, and S N Feofilaktova
April 1974, American journal of obstetrics and gynecology,
Copied contents to your clipboard!